Dasatinib-induced restoration of donor chimerism in BCR-ABL1-positive ALL after failure of imatinib therapy and allo-SCT.
Quintás-Cardama
A
A
Cortes
J
J
D000293:Adolescent; D001549:Benzamides; D003131:Combined Modality Therapy; D000069439:Dasatinib; D017809:Fatal Outcome; D016313:Genes, abl; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D010879:Piperazines / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000628:therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D013844:Thiazoles / Q000627:therapeutic use*; D018183:Transplantation Chimera
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D013844:Thiazoles; D000068877:Imatinib Mesylate; D000069439:Dasatinib